Indian government orders new drug-making standards following deaths overseas
The Indian government has mandated new drug manufacturing standards this year for the country's pharmaceutical companies, media reports said.
However, smaller firms are requesting a delay due to their existing financial burdens, as per a government notification as quoted by PTC News.
The Indian government tightened scrutiny after several deaths were reported overseas which were allegedly associated with drugs manufactured in India since 2022.
Aimed at revitalising the reputation of Indian pharmaceutical companies, the government's notification says as quoted by PTC News that "manufacturers must ensure the quality, safety, and efficacy of pharmaceutical products, assuming full responsibility for their suitability and compliance".
As per the notification, companies are required to conduct tests on ingredients and maintain adequate samples of intermediate and final products before marketing the finished product.
According to reports, the government has set a six-month deadline for major drug makers to address the concerns. Smaller firms have been given a year time to take the measures.
IBNS
Senior Staff Reporter at Northeast Herald, covering news from Tripura and Northeast India.
Related Articles
UN issues dire warning: Asia faces rising cyclones and flooding like never before
Across southeast Asia, record-breaking rains and flooding caused by back-to-back tropical storms have claimed hundreds of lives and brought devastation and displacement upon entire communities, UN agencies said on Tuesday.
Hidden mental health cost of birth control pills? Study finds shocking link
A new study has suggested that the use of contraceptive pills may have a hidden cost: impaired mental health.
Stunning drop! India reports 49% fall in annual new HIV cases
The Indian government has announced that the country recorded a nearly 49 per cent decline in annual new HIV infections between 2010 and 2024.
WHO describes obesity as a 'chronic disease', backs wider use of weight-loss medicines
The UN World Health Organization (WHO) has issued its first guideline on the use of a new class of weight-loss medicines, marking a significant shift in global health policy as obesity rates continue to rise.
Latest News
Prime Minister Mark Carney to attend FIFA World Cup 2026 Final Draw in Washington
Germany arrests two Iraqi nationals over suspected Islamic State links
Spanish tourist stabbed at Berlin Holocaust Memorial testifies in terror trial
Madras HC slams TN Govt for 'wilful disobedience' after Karthigai Deepam not lit at ancient pillar
